DR. STEVEN P WEINSTEIN, MD, PHD
Osteopathic Medicine at Dunham Rd, Hartsdale, NY
License number
New York 165824
Category
Osteopathic Medicine
Type
Endocrinology, Diabetes & Metabolism
Address
Address
28 Dunham Rd, Hartsdale, NY 10530
Phone
(914) 255-4186
Professional information
Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist
US Patent:
2014007, Mar 13, 2014
Filed:
Sep 4, 2013
Appl. No.:
14/017333
Inventors:
Neil GRAHAM - Croton-on-Hudson NY, US
Jennifer Davidson HAMILTON - Hopewell Junction NY, US
Stephane C. KIRKESSELI - Paris, FR
Sudeep KUNDU - New York NY, US
Jeffrey MING - Bridgewater NJ, US
Allen RADIN - New York NY, US
Ross E. ROCKLIN - Basking Ridge NJ, US
Steven Paul WEINSTEIN - Hartsdale NY, US
Jennifer Davidson HAMILTON - Hopewell Junction NY, US
Stephane C. KIRKESSELI - Paris, FR
Sudeep KUNDU - New York NY, US
Jeffrey MING - Bridgewater NJ, US
Allen RADIN - New York NY, US
Ross E. ROCKLIN - Basking Ridge NJ, US
Steven Paul WEINSTEIN - Hartsdale NY, US
Assignee:
Regeneron Pharmaceuticals, Inc. - Tarrytown NY
International Classification:
A61K 39/395, A61K 31/58, A61K 31/573, A61K 45/06, C07K 16/28
US Classification:
4241721
Abstract:
The present invention provides methods for treating atopic dermatitis (AD). Also provided are methods for improving one or more AD-associated parameter(s), and methods for decreasing the level of at least one AD-associated biomarker in a subject in need thereof. The methods of the present invention comprise administering to a subject in need thereof a pharmaceutical composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody.
Dr. Steven P Weinstein, Hartsdale NY - MD (Doctor of Medicine)
Specialties:
Endocrinology, Diabetes & Metabolism, Endocrinology & Metabolism
Address:
28 Dunham Rd, Hartsdale 10530
(914) 593-1011 (Phone)
(914) 593-1011 (Phone)
Certifications:
Diabetes, Metabolism & Endocrinology, 1989, Internal Medicine, 1988
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Albert Einstein College of Medicine of Yeshiva University
Montefiore Medical Center-Moses Division
Mount Sinai Hospital
Albert Einstein College of Medicine of Yeshiva University
Montefiore Medical Center-Moses Division
Mount Sinai Hospital
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
US Patent:
2014005, Feb 27, 2014
Filed:
Aug 20, 2013
Appl. No.:
13/971334
Inventors:
Marius ARDELEANU - White Plains NY, US
Namita A. GANDHI - New York NY, US
Neil GRAHAM - Croton-on-Hudson NY, US
Stephane C. KIRKESSELI - Paris, FR
Sudeep KUNDU - New York NY, US
Ross E. ROCKLIN - Basking Ridge NJ, US
Allen RADIN - New York NY, US
Steven P. WEINSTEIN - Hartsdale NY, US
Jennifer Davidson HAMILTON - Hopewell Junction NY, US
Jeffrey MING - Bridgewater NJ, US
Namita A. GANDHI - New York NY, US
Neil GRAHAM - Croton-on-Hudson NY, US
Stephane C. KIRKESSELI - Paris, FR
Sudeep KUNDU - New York NY, US
Ross E. ROCKLIN - Basking Ridge NJ, US
Allen RADIN - New York NY, US
Steven P. WEINSTEIN - Hartsdale NY, US
Jennifer Davidson HAMILTON - Hopewell Junction NY, US
Jeffrey MING - Bridgewater NJ, US
Assignee:
REGENERON PHARMACEUTICALS, INC. - Tarrytown NY
SANOFI - Paris
SANOFI - Paris
International Classification:
C07K 16/28, A61K 39/395, A61K 45/06
US Classification:
4241731
Abstract:
The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.
Use Of An Il-1 Antagonist For Treating Arthritis
US Patent:
7361350, Apr 22, 2008
Filed:
Feb 11, 2005
Appl. No.:
11/056730
Inventors:
Scott Mellis - New Rochelle NY, US
Neil Stahl - Carmel NY, US
Allen Radin - New York NY, US
Steven Weinstein - Hartsdale NY, US
Denise Calaprice - Nyack NY, US
Margaret Karow - Putnam Valley NY, US
Joanne Papadopoulos - LaGrangeville NY, US
Neil Stahl - Carmel NY, US
Allen Radin - New York NY, US
Steven Weinstein - Hartsdale NY, US
Denise Calaprice - Nyack NY, US
Margaret Karow - Putnam Valley NY, US
Joanne Papadopoulos - LaGrangeville NY, US
Assignee:
Regeneron Pharmaceuticals, Inc. - Tarrytown NY
International Classification:
A61K 39/00, C07K 14/715
US Classification:
4241851, 4241921, 514 12, 530350
Abstract:
Methods of treating, inhibiting, or ameliorating arthritis, including rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis, or juvenile rheumatoid arthritis, in a human subject in need thereof, comprising administering to a subject in need a therapeutic amount of an interleukin 1 (IL-1) antagonist, wherein arthritis inhibited, or ameliorated. The IL-1 antagonist is an IL-1-specific fusion protein comprising an IL-1 binding portion of the extracellular domain of human II-1RAcP, an IL-1 binding portion of the extracellular domain of human IL-1RI, and a multimerizing component antagonist, preferably comprising a sequence selected from the group consisting of SEQ ID NO:4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, or a substantially identical sequence.
Methods Of Using Il-1 Antagonists To Reduce C-Reactive Protein
US Patent:
2006017, Aug 3, 2006
Filed:
Feb 2, 2006
Appl. No.:
11/346007
Inventors:
Steven Weinstein - Hartsdale NY, US
Margaret Karow - Putnam Valley NY, US
Allen Radin - New York NY, US
William Roberts - Scarsdale NY, US
Li-Hsien Wang - Somers NY, US
Scott Mellis - New Rochelle NY, US
Margaret Karow - Putnam Valley NY, US
Allen Radin - New York NY, US
William Roberts - Scarsdale NY, US
Li-Hsien Wang - Somers NY, US
Scott Mellis - New Rochelle NY, US
International Classification:
A61K 39/395, A61K 38/17
US Classification:
424145100, 514012000
Abstract:
Methods of reducing C-reactive protein (CRP) in a subject, comprising administering to the subject a therapeutic amount of an interleukin 1 (IL-1) antagonist, wherein CRP is reduced. The IL-1 antagonist is preferably an IL-1-binding fusion protein (IL-1 trap), preferably comprising SEQ ID NO:2.